People with migraines experience restless legs syndrome at twice the normal rate

About one in five people who suffer from migraines also experience restless legs syndrome, roughly double the prevalence observed in the general public. This elevated frequency is highly pronounced among patients who endure chronic head pain or migraines accompanied by visual auras. The meta-analysis detailing these patterns was published in the Journal of Sleep Research.

Migraine is a neurological disorder characterized by recurrent attacks of throbbing head pain, often alongside nausea and extreme sensitivity to light or sound. Restless legs syndrome is a sensorimotor condition defined by an overwhelming urge to move the lower limbs. Patients typically experience uncomfortable crawling or aching sensations that worsen during periods of rest, particularly at night, and find temporary relief only through physical movement.

Medical professionals have noted that these two distinct conditions frequently appear in the same patients. To better understand this overlap, Simona Raimo, a researcher at the Magna Graecia University of Catanzaro in Italy, led a team to investigate the exact prevalence and clinical factors uniting the two disorders. The researchers aimed to aggregate existing data to offer distinct clinical guidance on how to manage patients facing both ailments simultaneously.

Single medical studies often involve a restricted number of participants, which can severely limit the statistical reliability of their conclusions. To overcome this hurdle, the researchers conducted a meta-analysis, a statistical technique that pools data from multiple independent studies to reveal broader patterns. Raimo and her team eventually isolated 30 high-quality studies published previously.

In total, the aggregated data encompassed 20,781 adult participants who had been diagnosed with migraines. Within this massive sample, 3,343 individuals also carried a full diagnosis of restless legs syndrome. By combining the available hospital data, the researchers calculated an overall pooled prevalence of 20 percent. For context, restless legs syndrome affects roughly 5 to 10 percent of the general population.

The researchers also looked at demographic traits to see if specific populations were at higher risk. Advancing age emerged as a consistent factor across the reviewed studies. Older adults naturally experience gradual changes in their dopamine production and iron metabolism, potentially explaining the higher rate of the sleep disorder in older age brackets. Although migraines are generally more common in women, sex did not produce statistically significant differences regarding the co-occurrence of the two conditions.

The specific type of migraine a patient experiences plays a major role in their overall risk profile. Migraine with aura involves sensory disturbances, such as seeing flashing lights or experiencing blind spots, that precede the onset of actual head pain. The researchers found an elevated association between restless legs syndrome and both chronic migraines and migraines with aura.

Conversely, no association was found for individuals who experience episodic migraines without an accompanying aura. The researchers suggest that as migraines become more frequent and progress into a chronic state, the physical signs of the sleep disorder become more apparent. The disease chronification process may amplify shared neurophysiological pathways in the human nervous system.

This progression aligns with a medical concept known as central sensitization. When the brain and spinal cord receive constant pain signals over many years, the nervous system can become hyper-reactive. Normal sensory inputs are suddenly processed as painful or intensely uncomfortable sensations. The researchers propose that chronic sensory input from frequent headaches, combined with the sensory dysregulation of restless legs, amplifies this heightened state of physiological alert.

Beyond clinical diagnoses, behavioral symptoms heavily influenced the co-occurrence of these conditions. Patients coping with both ailments were much more likely to report severe depressive symptoms, higher overall pain intensity, and poor sleep quality compared to those with migraines alone. Symptoms of anxiety did not reach a statistically significant association, suggesting the emotional burden leans more heavily toward depression than physical hyperarousal.

Sleep disturbances play a particularly destructive role in this dual cycle. Restless legs syndrome often involves involuntary muscle twitches that occur during actual sleep. These sudden movements produce tiny nervous system awakenings, known as micro-arousals, that prevent a person from reaching deep, restorative stages of rest. Severe sleep deprivation is a well-documented trigger for intense migraines, which creates a negative feedback loop where poor sleep generates physical pain, and physical pain disrupts rest.

The exact biological mechanisms linking migraines and restless legs syndrome remain an active area of widespread scientific investigation. One major leading theory involves the brain’s dopaminergic system. Dopamine is a chemical messenger that helps the nervous system regulate physical movement, human mood, and sensory processing.

In restless legs syndrome, abnormalities in specific dopamine pathways alter sensory processing in the spinal cord and cortex, resulting in nocturnal restlessness. In individuals with migraines, there is modern medical evidence that the brain becomes highly sensitive to dopamine. This heightened sensitivity can trigger physical symptoms like frequent yawning, intense nausea, and gastrointestinal issues just before a headache episode takes hold.

Iron regulation provides another potential biological overlap. Iron is a necessary molecular element for the human brain to synthesize dopamine properly. Patients with restless legs syndrome frequently exhibit iron deficiencies in the central nervous system, while individuals with frequent migraines often show abnormal iron accumulation in specific deep brain regions.

Recognizing this medical overlap has immediate implications for patient treatment, primarily because commonly prescribed medications can cause adverse physical interactions. Doctors frequently prescribe specific antidepressants or anti-nausea drugs to help patients manage migraine symptoms. Some of these pharmaceuticals can inadvertently trigger or exacerbate the uncomfortable physical sensations associated with restless legs syndrome.

The reverse medical reaction is also true in many hospital settings. Dopamine agonists are a specific class of drugs standardly used to calm limb movements in patients with movement disorders. If given to someone with a history of migraines, these same medications can provoke severe headache episodes. The researchers suggest that clinicians screen migraine patients for sleep disorders before finalizing a pharmaceutical protocol.

If a patient suffers from both conditions, doctors may need to pivot to alternative medications, such as specific anticonvulsant drugs, that can simultaneously soothe irritated nerves without aggravating either disorder. The study authors also advise non-pharmacological interventions, including strict sleep hygiene protocols, psychological therapies, and regular physical exercise. These lifestyle modifications can improve sleep efficiency and lift depressive symptoms without the risk of dangerous drug interactions.

The researchers outlined a few limitations in the available clinical data. The 30 studies utilized varying diagnostic questionnaires to identify sleep disorders, which introduced a high degree of statistical heterogeneity into the final results. Very few past studies have categorized patients using the most updated international criteria for headache disorders.

Future research should incorporate modern imaging techniques to observe the brains of patients experiencing both conditions simultaneously. Tracking iron levels, dopamine receptor activity, and the brain’s electrical excitability over a longer time horizon could isolate the precise biological origin point of this overlap. By tracking these variables over several years, scientists hope to develop targeted therapies that soothe the nervous system entirely.

The study, “Migraine and Restless Legs Syndrome: A Meta-Analysis,” was authored by Florindo d’Onofrio, Maria Cropano, Giada Panzino, Mariachiara Gaita, Giulio Cicarelli, Piero Barbanti, Gerardo Casucci, Simona Raimo, and Antonio Costanzo.